HIV medications stop the virus from making copies ... to some people without HIV as part of a preexposure prophylaxis (PrEP) regimen. Cytochrome P4503A, or CYP3A, is an enzyme in the liver that ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
The analysis, based on data from sources including the USP Medicine Supply Map, found that 71% of the drugs identified as the most vulnerable are injectables, including sodium chloride injection, ...
When breakthrough infections have been reported, they have typically occurred when people on PrEP have been exposed to HIV that has resistance to the drugs in PrEP. PrEP is an extremely effective way ...
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
People who inject drugs are eligible for PrEP in many countries. For example, in the United States, the Centers for Disease Control and Prevention recommends PrEP if you have an injection partner ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
Hosted on MSN1mon
Georgia leads in U.S. HIV cases. Here’s why the lifesaving drug PrEP faces barriers in the state.Preexposure prophylaxis, known as PrEP, reduces the risk of new HIV ... She hopes to stay on the drug, but the U.S. list price for lenacapavir as an HIV treatment averages about $40,000 a year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback